Filing Details
TREACE MEDICAL CONCEPTS, INC. (NASDAQ:TMCI) filed a Form 8-K with the Securities and Exchange Commission on November 06, 2026, disclosing a material event.
8k filedNASDAQ:TMCI
TREACE MEDICAL CONCEPTS, INC. (TMCI) Reports Material Event to SEC
TREACE MEDICAL CONCEPTS, INC. (NASDAQ:TMCI) filed a Form 8-K with the Securities and Exchange Commission on November 06, 2026, disclosing a material event.
At publication ·
What changed
TREACE MEDICAL CONCEPTS, INC. (NASDAQ:TMCI) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- TREACE MEDICAL CONCEPTS filed a Form 8-K with the SEC on November 6, 2026, disclosing a material event requiring shareholder attention.
- The company's stock trades at $4.18 with a market capitalization of $183.6 million as a healthcare company.
- Material events reported via 8-K can include leadership changes, acquisitions, asset sales, or financial guidance updates.
Market Context
TREACE MEDICAL CONCEPTS, INC.'s stock currently trades at $4.18 with a market capitalization of $183.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for TREACE MEDICAL CONCEPTS, INC.'s stock.
All SEC filings for TREACE MEDICAL CONCEPTS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TMCI Stock Page
Frequently Asked Questions
Where can I read TMCI's SEC filings?
Browse all filings on our TMCI SEC filings page.
What types of SEC filings does TREACE MEDICAL CONCEPTS, INC. file?
Public companies like TREACE MEDICAL CONCEPTS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
